A consultation-led, prescription weight-loss service — assessed and supervised by a GPhC-registered pharmacist, with a review every month.
Weight-loss treatment isn't right for everyone. We'll always give you an honest assessment.
See if it's right for you →These are prescription-only medicines, supplied only after a face-to-face assessment by a GPhC-registered pharmacist. Treatment is started on prescription where it's clinically appropriate; pricing is confirmed at your consultation.
Supports sustainable weight reduction and metabolic balance through dual hormone targeting.
Learn More
Clinically proven to curb appetite and reduce calorie intake for effective long-term results.
Learn More
New — MHRA approved June 2026The UK's first daily GLP-1 weight-loss tablet — launching soon. Register your interest today.
Learn More| Treatment Benefits | Mounjaro | Wegovy | Wegovy Pill |
|---|---|---|---|
| Approach | Dual-action mechanism supporting appetite | Focused appetite regulation for steady | Same semaglutide action, daily tablet |
| Weight Loss Potential | Up to 20% body weight reduction | Clinically proven lose upto 15% body weight | ~17% in 64-week trial |
| How It's Taken | Once-weekly injection for long-lasting | Once-weekly injection | Once-daily tablet — no needles |
| Additional Benefits | Supports metabolic health | Helps reduce daily cravings | Travel-friendly, no fridge needed |
| Best For | Those seeking powerful, | Those looking for targeted | Those preferring needle-free |
| Pharmacist Oversight | Personalized, in-person support | Personalized, in-person support | Personalized, in-person support |
| * Either BMI above 30 or more than 27 with a cardiovascular disease | |||
Eligibility, pricing and how weight-loss treatment works at our Timperley pharmacy.
Eligibility usually depends on your BMI and any weight-related health conditions. As a general guide, treatment may be suitable for a BMI of 30 or above, or 27 or above with a weight-related condition. A pharmacist confirms your suitability at your face-to-face assessment.
They are not suitable in pregnancy or while breastfeeding, and may not be appropriate with certain medical histories. Your pharmacist reviews your health and medicines first to make sure treatment is safe for you.
These are MHRA-licensed medicines supplied by a GPhC-registered pharmacy after an in-person suitability assessment, with monthly reviews to monitor your progress and safety. We only supply treatment when it is appropriate for you.
Yes — you can check your BMI on our site to see whether treatment may be relevant. A BMI figure is only a starting point; your pharmacist makes the final suitability decision at your appointment.
Pricing depends on the medicine and dose, and is confirmed at your consultation. There are no hidden fees — your pharmacist explains the full cost before you start, and your monthly reviews are included.
Yes. Your face-to-face monthly review with the pharmacist is part of your treatment — we don't charge extra to monitor your progress and keep you safe.
We are a private pharmacy service. We can advise on NHS routes where relevant, but treatment with us is self-funded and starts faster than typical NHS waiting times.
As a general private guide, treatment may be suitable with a BMI of 30 or above, or 27 or above if you have a weight-related health condition such as high blood pressure, high cholesterol or type 2 diabetes. Your pharmacist makes the final decision at your face-to-face assessment.
WeightGone